The high-affinity IgG receptor, FcγRI, plays a central role in antibody therapy of experimental melanoma

Translated title of the contribution: The high-affinity IgG receptor, FcγRI, plays a central role in antibody therapy of experimental melanoma

L. Bevaart, J.H.M. Jansen, M.J. van Vugt, J.S. Verbeek, J.G.J. van de Winkel, J.H.W. Leusen

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionThe high-affinity IgG receptor, FcγRI, plays a central role in antibody therapy of experimental melanoma
Original languageUndefined/Unknown
Pages (from-to)1261-1264
Number of pages4
JournalCancer Research
Volume66
Publication statusPublished - 2006

Cite this